Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSAcetohexamide is a first generation sulfonylurea that inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel (KIR6.2) with Ki values of 22.9 and 14.2 µM in HEK293 cells transfected with the human receptor and in rat brain, respectively.1 It is metabolized to the hypoglycemic compound L-hydroxyhexamide in vivo.2,3 Formulations containing acetohexamide have previously been used in the treatment of type 2 diabetes.
WARNING This product is not for human or veterinary use.
1. Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K+ channel Kir6.2 combination expressed in HEK-
2. The nature of the metabolites of acetohexamide in the rat and in the human. J. Pharmacol. Exp. Ther. 149(2), 272-279 (1965).
3. Hypoglycemic effect of S(−)-